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Abstract  
In this study, we introduced a new simple effective technique for the treatment 
of diabetic retinopathy by the treatment of the periphery of the retina by transscleral 
micropulse diode laser (Taha Technique). Macular edema was improved and 
vitreous hemorrhage was disappeared in most of the cases.    
Introduction/Background: 
Micropulse Diode Laser Photocoagulation (MD) is designed to target The 
Retinal Pigment Epithelium (RPE) melanocytes while avoiding photoreceptors 
damage. The term “subthreshold” refers to photocoagulation that does not produce 
visible intraretinal damage or visible scarring either during or after treatment. It is 
well known that burns cannot be detected by clinical examination or by Intravenous 
Fluorescein Angiography (IVFA) and Fundus Autofluorescene (FAF) 1,2 . 
Photocoagulation of all layers of retina is not needed to get the therapeutic 
effect on the retina by laser. The RPE is essential for repairing the outer and inner 
blood-retinal barrier regardless of the type and location of laser application. The 
absence of micro-pulse chorioretinal laser damage permit retreatment of the same 
area. The absence of chorioretinal scaring allows for an overlapping application of 
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burns. Frequent retreatment of involved retinal areas is also possible without fear of 
creating confluent retinal scarring 3. 
When the threshold of sublethal cellular injury is reached via the cumulative 
addition of denatured proteins, transcriptional activation of cytokine expression, 
release of growth factors and up regulation of matrix metalloproteinases occurs. It 
has the ability to up regulate various biochemical mediators with anti-angiogenic 
activity, such as Pigment Epithelium Derived Growth Factor (PEDGF). Also, the 
treatment by micro-pulse laser stimulates the release of factors that increase 
angiotensin II and increase receptor activity, enabling inhibition of Vascular 
Endothelial Growth Factor (VEGF).The reduction in VEGF also reduces vascular 
permeability 4,5 . 
Patients & Methods: 
This study included 46 eyes of 34 patients who had diabetic macular edema 
and/or proliferative diabetic retinopathy. The Patients in this study were divided into 
2 groups: Group (1) has macular edema thickness less than 400um. Group (2) has 
proliferative diabetic retinopathy with vitreous hemorrhage. Transscleral 
Micropulse Diode Laser treatment was given to the periphery of the retina. Laser 
sessions ranged from 1 to 3 in the first group and up to 5 sessions in the second 
group. The same laser parameters were used  for  each  patient. Only the number of 
laser shots varied between patients. Pre- laser treatment and in follow up, visual  
acuity , OCT, colored  fundus photo and fluorescein angiography  were  done. 
Results: 
Patients follow up ranged from one month to one year. Visual acuity were 
improved in 68% of treated eyes  in group 1 , and  in  84 % of  eyes in group 2. 
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Statistically significant reduction of macular edema was in 70 % of eyes in group 1. 
Total disappearance of vitreous hemorrhage and reduction of diabetic retinopathy 
was observed in 80 % of eyes in group 2. No adverse laser events occurred, no laser 
lesions were detectable clinically or angiographically after treatment. 
 
Group (1): 
 
Figure (1): Case number 1 with diabetic macular edema which shows marked 
improvement within 3 months after Micropulse Diode Laser Photocoagulation. 
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Figure (2): Case number 2 with diabetic macular edema which shows marked 
improvement within 3 months after Micropulse Diode Laser Photocoagulation. 
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Figure (3): Case number 3 with diabetic macular edema which shows marked 
improvement within 3 months after Micropulse Diode Laser Photocoagulation. 
 
 
Figure (4): Case number 4 with diabetic macular edema which shows marked 
improvement within 2 weeks after Micropulse Diode Laser Photocoagulation. 
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Figure (5): Case number 5 with diabetic macular edema which shows marked 
improvement within 5 months after Micropulse Diode Laser Photocoagulation. 
 
 
Figure (6): Case number 6 with diabetic macular edema which shows marked 
improvement within 3 months after Micropulse Diode Laser Photocoagulation. 
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Figure (7): Case number 7 with diabetic macular edema which shows marked 
improvement within 3 months after Micropulse Diode Laser Photocoagulation. 
 
 
Figure (8): Case number 8 with diabetic macular edema which shows marked 
improvement within 2 months after Micropulse Diode Laser Photocoagulation. 
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Figure (9): Case number 9 with diabetic macular edema which shows marked 
improvement within 3 months after Micropulse Diode Laser Photocoagulation. 
 
 
 
Figure (10): Case number 10 with diabetic macular edema which shows marked 
improvement within 3 weeks after Micropulse Diode Laser Photocoagulation. 
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Figure (11): Case number 11 with diabetic macular edema which shows marked 
improvement within 3 months after Micropulse Diode Laser Photocoagulation. 
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Group (2): 
 
Figure (12): Case number 12 with proliferative diabetic retinopathy and vitrous 
heamorrhage which shows marked improvement within 5 months after Micropulse 
Diode Laser Photocoagulation. 
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Figure (13): Case number 13 with proliferative diabetic retinopathy and vitrous 
heamorrhage which shows marked improvement within 2 months after Micropulse 
Diode Laser Photocoagulation. 
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Figure (14): Case number 14 with proliferative diabetic retinopathy and vitrous 
heamorrhage which shows marked improvement within 5 months after Micropulse 
Diode Laser Photocoagulation. 
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Figure (15): Case number 15 with proliferative diabetic retinopathy and vitrous 
heamorrhage which shows marked improvement within 4 months after Micropulse 
Diode Laser Photocoagulation. 
 
Conclusions: 
Transscleral  micropulse diode laser treatment of diabetic macular edema and 
proliferative diabetic retinopathy (Taha Technique) is an easy new technique, 
effective and safe treatment way. 
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